SCHEMBL26189489

SCHEMBL26189489

c1ccc(-c2ccc3ccc(-c4ccc5c6ccccc6c6ccccc6c5c4)cc3c2)nc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.47
▸ LMNA P02545 3/20 0.47
▸ TP53 P04637 2/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ PKM P14618 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ KLF5 Q13887 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ DHODH Q02127 1/20 0.44
▸ ABL1 P00519 1/20 0.44
▸ PRMT5 O14744 2/20 0.44
▸ WDR77 Q9BQA1 1/20 0.44
▸ PIK3CD O00329 1/20 0.43
▸ PIK3CA P42336 1/20 0.43
▸ PI4KA P42356 1/20 0.43
▸ PIK3CG P48736 1/20 0.43
▸ PI4KB Q9UBF8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17426595 0.95 SMN1; SMN2 (0.52) KDM4ELMNATP53SMN1; SMN2ALDH1A1
SCHEMBL17426589 0.95 ABL1 (0.48) KDM4ELMNATP53SMN1; SMN2ALDH1A1
SCHEMBL17426593 0.90 SMN1; SMN2 (0.51) KDM4ELMNATP53SMN1; SMN2ALDH1A1
SCHEMBL13321297 0.89 KDM4E (0.52) KDM4ELMNATP53SMN1; SMN2ALDH1A1
SCHEMBL17229021 0.89 KDM4E (0.52) KDM4ELMNATP53SMN1; SMN2ALDH1A1
SCHEMBL19497667 0.88 KDM4E (0.54) KDM4ELMNATP53SMN1; SMN2ALDH1A1
SCHEMBL26260209 0.88 KDM4E (0.56) KDM4ELMNATP53SMN1; SMN2ALDH1A1
SCHEMBL16641362 0.86 PRMT5 (0.46) KDM4ELMNATP53SMN1; SMN2DHODH
SCHEMBL17426598 0.86 DHODH (0.47) KDM4ELMNATP53SMN1; SMN2ALDH1A1
SCHEMBL12277737 0.86 KDM4E (0.48) KDM4ELMNATP53SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230272274-A1 FORMULATIONS AND APPLICATIONS THEREOF IN OPTOELECTRONIC FIELD Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-08-31 — — US disclosed
US-20230255112-A1 ORGANIC COMPOUNDS AND APPLICATIONS THEREOF IN OPTOELECTRONIC FIELD ZHEJIANG BRILLIANT OPTOELECTRONIC TECHNOLOGY CO., LTD. (CN) 2023-08-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230255112-A1 ORGANIC COMPOUNDS AND APPLICATIONS THEREOF IN OPTOELECTRONIC FIELD OR10J3, AOX1, AOC3 KDM4E 4005/4885LMNA 3057/4885TP53 3846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback